Study of ARO-ATXN2 Injection in Adults With Spinocerebellar Ataxia Type 2
Clinical trial NCT06672445 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06672445
- Sponsor
- Arrowhead Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-17
- Primary completion
- 2026-12-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.